Challenges in Advancing Necrotizing Enterocolitis Research

Clinics in Perinatology

Volumn 46, Issue 1, 2019, Pages 19-27

  Battersby, Cheryl ^a   Modi, Neena ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Clinical trials; Necrotizing enterocolitis; Preclinical research

Indexed keywords

PROBIOTIC AGENT; BIOLOGICAL MARKER;

ABDOMINAL DISTENSION; CLINICAL RESEARCH; DIETARY SUPPLEMENT; DISEASE SURVEILLANCE; GESTATIONAL AGE; HEALTH CARE COST; HUMAN; HYPOXEMIA; LAPAROTOMY; NECROTIZING ENTEROCOLITIS; NUTRITIONAL INTOLERANCE; PNEUMATOSIS INTESTINALIS; POINT OF CARE TESTING; POPULATION RESEARCH; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VERY LOW BIRTH WEIGHT; FINANCIAL MANAGEMENT; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; NEWBORN; PROGNOSIS; PUBLIC-PRIVATE PARTNERSHIP; RISK ASSESSMENT;

BIOMARKERS; BIOMEDICAL RESEARCH; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERNATIONAL COOPERATION; PROGNOSIS; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RESEARCH SUPPORT AS TOPIC; RISK ASSESSMENT;

EID: 85058172454     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2018.10.002     Document Type: Review

References (45)

1. Battersby, C., Longford, N., Costeloe, K., et al., for the UK Neonatal Collaborative Necrotising Enterocolitis Study Group. Development of a gestational age-specific case definition for neonatal necrotizing enterocolitis. JAMA Pediatr 171 (2017), 256–263.
2. Gordon, P.V., Swanson, J.R., Attridge, J.T., et al. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?. J Perinatol 27 (2007), 661–671.
3. Gordon, P.V., Swanson, J.R., MacQueen, B.C., et al. A critical question for NEC researchers: can we create a consensus definition of NEC that facilitates research progress?. Semin Perinatol 41 (2017), 7–14.
4. Tam, A.L., Camberos, A., Applebaum, H., Surgical decision making in necrotizing enterocolitis and focal intestinal perforation: predictive value of radiologic findings. J Pediatr Surg 37 (2002), 1688–1691.
5. Rehan, V.K., Seshia, M.M., Johnston, B., et al. Observer variability in interpretation of abdominal radiographs of infants with suspected necrotizing enterocolitis. Clin Pediatr (Phila) 38 (1999), 637–643.
6. Mata, A.G., Rosengart, R.M., Interobserver variability in the radiographic diagnosis of necrotizing enterocolitis. Pediatrics 66 (1980), 68–71.
7. Battersby, C., Longford, N., Mandalia, S., et al., UK Neonatal Collaborative Necrotising Enterocolitis (UKNC-NEC) Study Group. Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012-13: a whole-population surveillance study. Lancet Gastroenterol Hepatol 2 (2017), 43–51.
8. Kliegman, R.M., Walsh, M.C., Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 17 (1987), 213–288.
9. Bell, M.J., Ternberg, J.L., Feigin, R.D., et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187 (1978), 1–7.
10. Battersby, C., Santhalingam, T., Costeloe, K., et al. Incidence of neonatal necrotising enterocolitis in high-income countries: a systematic review. Arch Dis Child Fetal Neonatal Ed 103 (2018), F182–F189.
11. Vermont Oxford Network (VON), Vermont oxford network database manual of operations: part 2: data definitions and data forms for infants born in 2013, 17th edition (R Release), 2012, Vermont Oxford Network, Burlington, VT.
12. Tommiska, V., Heinonen, K., Ikonen, S., et al. A National short-term follow-up study of extremely low birth weight infants born in finland in 1996–1997. Pediatrics, 107, 2001, e2.
13. Leistner, R., Piening, B., Gastmeier, P., et al. Nosocomial infections in very low birthweight infants in Germany: current data from the National Surveillance System NEO-KISS. Klin Padiatr 225 (2013), 75–80.
14. Ahle, M., Drott, P., Andersson, R.E., Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987-2009. Pediatrics 132 (2013), e443–e451.
15. Kastenberg, Z.J., Lee, H.C., Profit, J., et al. Effect of deregionalized care on mortality in very low-birth-weight infants with necrotizing enterocolitis. JAMA Pediatr 169 (2015), 26–32.
16. Fitzgibbons, S.C., Ching, Y., Yu, D., et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 44 (2009), 1072–1075.
17. Youn, Y.A., Kim, E.-K., Kim, S.Y., Necrotizing enterocolitis among very-low-birth-weight infants in Korea. J Korean Med Sci 30:Suppl 1 (2015), S75–S80.
18. Wojkowska-Mach, J., Rozanska, A., Borszewska-Kornacka, M., et al. Necrotising enterocolitis in preterm infants: epidemiology and antibiotic consumption in the Polish neonatology network neonatal intensive care units in 2009. PLoS One, 9, 2014, e92865.
19. Sharma, R., Hudak, M.L., Tepas, J.J. III, et al. Impact of gestational age on the clinical presentation and surgical outcome of necrotizing enterocolitis. J Perinatol 26 (2006), 342–347.
20. Niemarkt, H.J., de Meij, T.G., van de Velde, M.E., et al. Necrotizing enterocolitis: a clinical review on diagnostic biomarkers and the role of the intestinal microbiota. Inflamm Bowel Dis 21 (2015), 436–444.
21. Ng, P.C., Biomarkers of necrotising enterocolitis. Semin Fetal Neonatal Med 19 (2014), 33–38.
22. Thuijls, G., Derikx, J.P.M., van Wijck, K., et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 251 (2010), 1174–1180.
23. Neu, J., Necrotizing enterocolitis: the mystery goes on. Neonatology 106 (2014), 289–295.
24. Neu, J., Pammi, M., Pathogenesis of NEC: impact of an altered intestinal microbiome. Semin Perinatol 41 (2017), 29–35.
25. Denning, T.L., Bhatia, A.M., Kane, A.F., et al. Pathogenesis of NEC: role of the innate and adaptive immune response. Semin Perinatol 41 (2017), 15–28.
26. Stoll, B.J., Hansen, N.I., Bell, E.F., et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314 (2015), 1039–1051.
27. Yee, W.H., Soraisham, A.S., Shah, V.S., et al. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 129 (2012), e298–e304.
28. Isayama, T., Lee, S.K., Mori, R., et al. Comparison of mortality and morbidity of very low birth weight infants between Canada and Japan. Pediatrics 130 (2012), e957–e965.
29. Chen, F., Bajwa, N.M., Rimensberger, P.C., et al., Swiss Neonatal Network. Thirteen-year mortality and morbidity in preterm infants in Switzerland. Arch Dis Child Fetal Neonatal Ed 101 (2016), F377–F383.
30. Hossain, S., Shah, P.S., Ye, X.Y., et al. Outcome comparison of very preterm infants cared for in the neonatal intensive care units in Australia and New Zealand and in Canada. J Paediatr Child Health 51 (2015), 881–888.
31. Isayama, T., Shah, P.S., Ye, X.Y., et al. Adverse impact of maternal cigarette smoking on preterm infants: a population-based cohort study. Am J Perinatol 32 (2015), 1105–1111.
32. Gagliardi, L., Bellu, R., Cardilli, V., et al. Necrotising enterocolitis in very low birth weight infants in Italy: incidence and non-nutritional risk factors. J Pediatr Gastroenterol Nutr 47 (2008), 206–210.
33. Statnikov, Y., Ibrahim, B., Modi, N., A systematic review of administrative and clinical databases of infants admitted to neonatal units. Arch Dis Child Fetal Neonatal Ed 102 (2017), F270–F276.
34. Jacobs, S.E., Tobin, J.M., Opie, G.F., et al., ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 132 (2013), 1055–1062.
35. Costeloe, K., Hardy, P., Juszczak, E., et al., Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387 (2016), 649–660.
36. Martin, L., Hutchens, M., Hawkins, C., et al. How much do clinical trials cost?. Nat Rev Drug Discov 16 (2017), 381–382.
37. European medicines Agency 2007 The European paediatric initiative: History of the Paediatric Regulation. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/09/WC500003693.pdf. Accessed April 6, 2018.
38. Department of Health and Human Services Food and Drug Administration 2016 Best Pharmaceuticals for Children Act and Pediatric Research Equity Act Status Report to Congress. Available at: https://www.fda.gov/downloads/scienceresearch/specialtopics/pediatrictherapeuticsresearch/ucm509815.pdf. Accessed April 6, 2018.
39. Webbe, J., Brunton, G., Ali, S., et al. Implementing and disseminating a core outcome set for neonatal medicine. BMJ Paediatr Open, 1, 2017, e000048.
40. Duffy, J., Rolph, R., Gale, C., et al., International Collaboration to Harmonise Outcomes in Pre-eclampsia (iHOPE). Core outcome sets in women's and newborn health: a systematic review. BJOG 124 (2017), 1481–1489.
41. Offringa, M., Needham, A.C., Chan, W.W., StaR Child Health Group. StaR Child Health: improving global standards for child health research. Early Hum Dev 89 (2013), 861–864.
42. Mills, L., Modi, N., Clinician enteral feeding preferences for very preterm babies in the UK. Arch Dis Child Fetal Neonatal Ed 100 (2015), F372–F373.
43. Gale, C., Hyde, M.J., Modi, N., WHEAT trial development group Research ethics committee decision-making in relation to an efficient neonatal trial. Arch Dis Child Fetal Neonatal Ed 102 (2017), F291–F298.
44. Gale, C., Modi, N., WHEAT trial development group Neonatal randomised point-of-care trials are feasible and acceptable in the UK: results from two national surveys. Arch Dis Child Fetal Neonatal Ed 101 (2016), F86–F87.
45. International Neonatal Consortium. Available at: https://c-path.org/programs/inc/. Accessed April 6, 2018.